Related Experiment Video
Updated: Apr 4, 2026
05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
3.5K
Prosthetic Pulmonary Valve Stenosis: A Different Way to Solve the Problem
Thomas Schroeter1, Philipp Lurz2, Philipp Kiefer1
1Department of Cardiac Surgery, Heart Center Leipzig, University of Leipzig, Leipzig, Germany.
The Annals of Thoracic Surgery
|September 11, 2015
Summary
A transcatheter pulmonary valve replacement avoided repeat open-heart surgery for an 84-year-old man with a failing bioprosthesis. This minimally invasive procedure offered a successful alternative, preventing further major cardiovascular interventions.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Background:
- The patient, an 84-year-old male, had a history necessitating consideration for a third major cardiovascular surgery.
- A functionally stenotic bioprosthesis in the pulmonary position presented a significant clinical challenge.
Observation:
- The Melody Transcatheter Pulmonary Valve was selected as the intervention.
- The implantation was performed in the pulmonary position, targeting the stenotic bioprosthesis.
Findings:
- The transcatheter pulmonary valve implantation procedure was completed without any complications.
- The intervention yielded good clinical results, indicating successful valve function.
Implications:
- This case demonstrates the feasibility and effectiveness of transcatheter valve implantation as an alternative to repeat open-heart surgery.
- Minimally invasive approaches like transcatheter pulmonary valve replacement can significantly improve outcomes for elderly patients with complex cardiovascular conditions.
More Related Videos
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
468
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
468
01:27Mitral Stenosis IV: Nursing Management
381
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
381
01:25Mitral Regurgitation III: Medical Management
585
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
585
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
609
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
609
01:19Mitral Valve Prolapse III: Nursing Management
534
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
534
01:22Mitral Valve Prolapse II: Assessment and Management
1.1K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.1K